THE ROLE OF PHARMACY, HOSPITAL MANAGEMENT AND HEALTH INFORMATICS IN ADHERENCE TO MEDICAL TREATMENT AMONG DIABETIC PATIENTS

Main Article Content

Saeed mohammed Abdullah Alzahrani
Hashim Hamed Abdullah Alshamrani
Thaar murdhi al Qahtani
Anas Ali Mansi Alzahrani
Abdullah Ahmed Salem alqarni
Saleh abdullah al-awadh
Ahmed Mohammed Alamri
Mohammed Hamdan Shaddad Alshamrani
Badr Ali Alharthi
Walid Awadallah Saad Al Harithi

Keywords

Medication adherence, Quality of life, Diabetes mellitus, medical secretary role

Abstract

Background: Adherence to medical treatment is crucial for managing type 2 diabetes effectively and improving health outcomes. Nonadherence can lead to complications, increased healthcare costs, and decreased quality of life for patients. Understanding the factors influencing adherence and the roles of various healthcare professionals is essential for developing effective interventions. 


Objectives: This research article aims to assess the level of adherence to medical treatment among type 2 diabetes patients, identify factors influencing adherence, explore the impact of adherence on health outcomes and quality of life, evaluate interventions for improving adherence, and make recommendations for healthcare providers and policymakers. Additionally, the study aims to evaluate the roles of pharmacy, health informatics, and hospital management in promoting adherence to medical treatment. 


Conclusion: Factors such as health literacy, patient-related issues, and environmental barriers significantly impact treatment adherence among type 2 diabetes patients. The study emphasizes the crucial roles of medical secretaries, pharmacy technicians, pharmacists, health informatics, and hospital management in supporting patients and improving adherence. Addressing these factors and roles can enhance adherence to medical treatment, leading to better health outcomes and quality of life for type 2 diabetes patients. By implementing targeted interventions and promoting collaboration among healthcare providers, policymakers can work towards improving adherence and ultimately enhancing the overall well-being of individuals with type 2 diabetes.

Abstract 207 | pdf Downloads 82

References

1. Patient medication adherence: measures in daily practice. Jimmy B, Jose J. Oman Med J. 2011;26:155–159. [PMC free article] [PubMed] [Google Scholar]
2. Medication adherence: its importance in cardiovascular outcomes. Ho PM, Bryson CL, Rumsfeld JS. Circulation. 2009;119:3028–3035. [PubMed] [Google Scholar]
3. Assessment of medication adherence in type II diabetic patients: a cross-sectional study. Khotkar K, Chudhari S, Jadhav P. https://ortholibrary.in/doi/MGMJMS/pdf/10.5 005/jp-journals-10036-1142 MGM J Med Sci. 2017;4:65–69. [Google Scholar]
4. The unmet challenge of medication nonadherence. Kleinsinger F. Perm J. 2018;22:1–3. [PMC free article] [PubMed] [Google Scholar]
5. A community-based study on diabetes medication nonadherence and its risk factors in rural Tamil Nadu. Venkatesan M, Dongre AR, Ganapathy K. https://pubmed.ncbi.nlm.nih.gov/29899603/ Indian J Community Med. 2018;43:72–76. [PMC free article] [PubMed] [Google Scholar]
6. Barriers and facilitators to medication adherence: a qualitative study with general practitioners. Kvarnström K, Airaksinen M, Liira H. BMJ Open. 2018;8:0. [PMC free article] [PubMed] [Google Scholar]
7. A study of medication adherence and selfcare practices among type- 2 diabetes patients in Davangere. Anurupa MS, Aditya A, Angadi N. https://njcmindia.com/index.php/file/article/view /415 Int J Community Med. 2019;10 [Google Scholar]
8. Treatment compliance among previously diagnosed type 2 diabetics in a rural area in Southern India. Pattnaik S, Ausvi SM, Salgar A, Sharma D. https://pubmed.ncbi.nlm.nih.gov/31041225/ J Family Med Prim Care. 2019;8:919–922. [PMC free article] [PubMed] [Google Scholar]
9. Compliance to anti-diabetic drugs: observations from the diabetic clinic of a medical college in Kolkata, India. Mukherjee S, Sharmasarkar B, Das KK, Bhattacharyya A, Deb A. J Clin Diagn Res. 2013;7:661–665. [PMC free article] [PubMed] [Google Scholar]
10. Zomahoun HT, Moisan J, Lauzier S, Guillaumie L, Gregoire JP, Guenette L. Predicting noninsulin antidiabetic drug adherence sing a theoretical framework based on the theory of planned behavior in adults with type 2 diabetes: A prospective study. Medicine (Baltimore) 2016;95:e2954. [PMC free article] [PubMed] [Google Scholar]
11. Traina SB, Mathias SD, Colwell HH, Crosby RD, Abraham C. The Diabetes intention, attitude, and behavior questionnaire: evaluation of a brief questionnaire to measure physical activity, dietary control, maintenance of a healthy weight, and psychological antecedents. Patient Prefer Adherence. 2016;10:213–22. [PMC free article] [PubMed] [Google Scholar]
12. Guenette L, Lauzier S, Guillaumie L, Gregoire G, Gregoire JP, Moisan J. Patients' beliefs about adherence to oral antidiabetic treatment: A qualitative study. Patient Prefer Adherence. 2015;9:413–20. [PMC free article] [PubMed] [Google Scholar]
13. Wu P, Liu N. Association between patients' beliefs and oral antidiabetic medication adherence in a Chinese type 2 diabetic population. Patient Prefer Adherence. 2016;10:1161–7. [PMC free article] [PubMed] [Google Scholar]
14. Guenette L, Breton MC, Guillaumie L, Lauzier S, Gregoire JP, Moisan J. Psychosocial factors associated with adherence to non-insulin antidiabetes treatments. J Diabetes Complications. 2016;30:335–42. [PubMed] [Google Scholar]
15. Jafarian-Amirkhizi A, Sarayani A, Gholami K, Taghizadeh-Ghehi M, Heidari K, Jafarzadeh-Kohneloo A, et al. Adherence to medications, self-care activity, and HBA1c status among patients with type 2 diabetes living in an urban area of Iran. J Diabetes Metab Disord. 2018;17:165–72. [PMC free article] [PubMed] [Google Scholar]
16. Pashaki MS, Eghbali T, Niksima SH, Albatineh AN, Gheshlagh RG. Health literacy among Iranian patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab Syndr. 2019;13:1341–5. [PubMed] [Google Scholar]
17. Pourhabibi N, Mohebbi B, Sadeghi R, Shakibazadeh E, Sanjari M, Tol A, Yaseri M. Determinants of Poor Treatment Adherence among Patients with Type 2 Diabetes and Limited Health Literacy: A Scoping Review. J Diabetes Res. 2022;2022:1–10. doi: 10.1155/2022/2980250. [PMC free article] [PubMed] [Google Scholar]
18. Khosravi A, Ahmadzadeh K, Arastoopoor S, Tahmasbi R. Health literacy levels of diabetic patients referred to Shiraz health centers and its effective factors. Health Inf Manage. 2015;12:205. [Google Scholar] 19. Medford, Andrew R L, and Sharon Standen. “In praise of medical secretaries: pay and conditions should reflect crucial role of medical secretaries in clinical teams.” BMJ (Clinical research ed.) vol. 327,7421 (2003): 991. doi:10.1136/bmj.327.7421.991-a
20. Alis J, Blair M. Life as a medical secretary— a new learning experience for the aspiring consultant. BMJ. 2003 Feb 15;326(7385):403. 21. Orabone, Amanda Wojtusik et al. “Pharmacist-Managed Diabetes Programs: Improving Treatment Adherence and PatientOutcomes.” Diabetes, metabolic syndrome and obesity : targets and therapy vol. 15 1911-1923. 20 Jun. 2022, doi:10.2147/DMSO.S342936
22. Bodenheimer T, Sinsky C. From triple to quadruple AIM: care of the patient requires care of the provider. Ann Fam Med. 2014;12:573–576. doi: 10.1370/afm.1713 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
23. Norton MC, Haftman ME, Buzzard LN. Impact of physician-pharmacist collaboration on diabetes outcomes and health care use. J Am Board Fam Med. 2020;33:745–753. doi: 10.3122/jabfm.2020.05.200044 [PubMed] [CrossRef] [Google Scholar]
24. Healy AM, Shubrook JH, Schwartz FL, Cummings DM, Drake AJ, Tanenberg RJ. Endocrinologists’ opinions of diabetology as a primary care subspecialty. Clin Diabetes. 2018;36:168–173. doi: 10.2337/cd17-0097 [PMC free article] [PubMed] [CrossRef] [Google Scholar] [Ref list]
25. Saleem F, Hassali MA, Shafie AA. A crosssectional assessment of health-related quality of life (HRQoL) among hypertensive patients in Pakistan. Health Expect. 2014;17(3):388– 395. doi: 10.1111/j.1369-7625.2012.00765.x [PMC free article] [PubMed] [CrossRef] [Google Scholar]
26. Mishra R, Sharma SK, Verma R, Kangra P, Dahiya P, Kumari P, Sahu P, Bhakar P, Kumawat R, Kaur R, Kaur R, Kant R. Medication adherence and quality of life among type-2 diabetes mellitus patients in India. World J Diabetes 2021; 12(10): 1740- 1749 [PMID: 34754375 DOI: 10.4239 /wjd.v12.i10.1740]

27. Carrillo-Larco RM, Barengo NC, Albitres- Flores L, Bernabe-Ortiz A. The risk of mortality among people with type 2 diabetes in Latin America: A systematic review and meta-analysis of population-based cohort studies. Diabetes Metab Res Rev. 2019 May;35(4):e3139. [PubMed]
28. Vijan S. In the clinic.Type 2 diabetes. Ann. Intern. Med. 2010;152(5):ITC31–ITC35. doi: 10.7326/0003-4819-152-5-20100302001003. [PubMed] [CrossRef] [Google Scholar] [Ref list]
29. Fasanmade O.A., Odeniyi I.A., Ogbera A.O. Diabetic ketoacidosis: Diagnosis and management . Afr. J. Med. Med. Sci. 2008;37(2):99–105. [PubMed] [Google Scholar] [Ref list]
30. Patoulias D, Papadopoulos C, Stavropoulos K, Zografou I, Doumas M, Karagiannis A. Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors. J Clin Hypertens (Greenwich). 2020 Apr;22(4):562-571. [PMC free article] [PubMed]
31. Besemah, N. A., Sartika, R. A. D., & Sauriasari, R. (2021). Effect of Pharmacist Intervention on Medication Adherence and Clinical Outcomes of Type 2 Diabetes Mellitus Outpatients in Primary Healthcare in Indonesia. Journal of research in pharmacy practice, 9(4), 186–195. https://doi.org/10.4103/jrpp.JRPP_20_59
32. Lester, W. T., Zai, A. H., Chueh, H. C., & Grant, R. W. (2008). Diabetes information technology: designing informatics systems to catalyze change in clinical care. Journal of diabetes science and technology, 2(2), 275– 283. https://doi.org/10.1177/193229680800200218
33. Olomu, A., Kelly-Blake, K., Hart-Davidson, W., Gardiner, J., Luo, Z., Heisler, M., & Holmes-Rovner, M. (2022). Improving diabetic patients' adherence to treatment and prevention of cardiovascular disease (Office Guidelines Applied to Practice-IMPACT Study)-a cluster randomized controlled effectiveness trial. Trials, 23(1), 659. https://doi.org/10.1186/s13063-022-06581-6